OPEN END TURBO BULL - ELI LILLY & CO | Market Closed - Euronext Paris 12:30:01 2024-05-10 EDT | ||
| 12.47 EUR | -5.74% |
|
| Current month | -9.90% | ||
| 1 month | -0.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-05-10 | 12.47 | -5.74% |
| 24-05-09 | 13.23 | -2.58% |
| 24-05-08 | 13.58 | +1.49% |
| 24-05-07 | 13.38 | +14.07% |
Real-time Euronext Paris
Last update May 10, 2024 at 12:30 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Citi
|
| SM09C | |
| ISIN | DE000KJ41QS7 |
| Date issued | 2024-02-05 |
| Strike | 634.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.65 € |
|---|---|
| Lowest since issue | 5.41 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
787
USD
Average target price
850.4
USD
Spread / Average Target
+8.05%
- Stock Market
- Certificates
- SM09C Certificat
